Filing Flows › Teladoc Health (TDOC) › Q1 2026
Teladoc Health (TDOC) Q1 2026 earnings results (first quarter 2026)
10-Q filed Apr 30, 2026
Teladoc Health (TDOC) reported revenue of $614M for the first quarter 2026 (Q1 2026), -2% from a year earlier and -4% from the quarter before. Operating margin was -10.1%, net loss $63.8M (10.4% of revenue).
Teladoc Health, Q1 2026: revenue $614M (-2% year over year), operating margin -10.1%, net loss $63.8M, operating cash flow $9.5M. The chart follows the revenue to costs, profit and cash.
| Q1 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $614M | -4% | -2% |
| Operating profit | −$61.8M | — | — |
| Net earnings | −$63.8M | — | — |
| Operating cash flow | $9.5M | -89% | -40% |
| Free cash flow | $7.9M | -91% | -40% |
What changed
Revenue was $613.8M in Q1 2026, down 2% year over year and down 4% from the previous quarter. Access Fees was the largest line at 79% of revenue. Access Fees lost $41.1M year over year (down 8%), 265% of the total change.
Operating costs exceeded revenue by $61.8M, an operating margin of -10.1%. Total costs fell 10% while revenue fell 2%. The quarter ended with a net loss of $63.8M, wider than the previous quarter's $25.1M loss.
Operating cash flow was $9.5M (down 40% year over year). Non-cash charges added back $14.6M of share-based compensation. Working capital and other items added $58.7M. Capital expenditures of $1.7M left free cash flow of $7.9M.
Questions
What was Teladoc Health's revenue in the first quarter 2026?
Teladoc Health (TDOC) reported revenue of $614M for the first quarter 2026 (Q1 2026), -2% from a year earlier and -4% from the quarter before.
Was Teladoc Health profitable in the first quarter 2026?
Operating loss was $61.8M (-10.1% of revenue) and net loss $63.8M.
Source: Teladoc Health 10-Q on SEC EDGAR.